DALLAS, November 12, 2010 /PRNewswire via COMTEX/ -- The 'Top 10 drug discovery technologies (http://www.marketsandmarkets.com/Market-Reports/drug-discovery-41.html) - strategic analysis and global forecasts (2010 to 2015)' analyzes the top 10 drug discovery technologies with respect to market drivers, opportunities and trends in the diverse geographical regions including North America, Europe, Asia and rest of the world.
Browse market data tables and in-depth TOC on Top 10 drug discovery technologies - strategic analysis and global forecasts (2010 to 2015) http://www.marketsandmarkets.com/Market-Reports/drug-discovery-41.html Early buyers will receive 10% customization of reports.
The slow growth of the introduction of new blockbuster drugs is a major concern which the drug development companies are catering to by using these top technologies. The increasing utilization of HTS in the lead generation and increasing adoption of the technology by the academia are some of the prime market boosters for high throughput screening.
The global top 10 drug discovery technologies market is expected to be around $30.8 billion in 2010 and estimated to reach $54 billion mark in 2015, growing at a CAGR of 11.9% from 2010-2015. The market for high throughput screening accounts for the largest share with approximately 33% of the entire market for top 10 drug discovery technologies. This huge market share is mainly due to the increasing applications of cell based assays and robotics in the parallel screening of compounds.
Scope of the report This research report includes following drug discovery technologies: - High throughput screening (robotics and automation, cell based assays, miniaturization, high content screening and ultra high throughput screening) - Bioanalytical instruments (mass spectrometry, NMR, micro plate readers and chemotherapy instruments) - Pharmacogenomics - Combinatorial chemistry - Genomics (functional and structural genomics) - Biochips (DNA microarrays, lab on a chip, proteomics microarrays) - Bioinformatics - Proteomics (2DGE, two hybrid systems, isotope encoding and activity based assays) - RNAi (siRNA, miRNA, ddRNAi, short hairpin RNAs) - Nanotechnology (Atomic force microscopy, nano mass spectroscopy, dip pen nanolithography and other nanotechnologies) About MarketsandMarkets MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com
7557 Rambler Road
Suite 727, Dallas, TX 75231
http://marketsandmarkets.blogspot.com/ SOURCE MarketsandMarkets www.prnewswire.com Copyright (C) 2010 PR Newswire. All rights reserved -0- KEYWORD: Texas INDUSTRY KEYWORD: MTC
PHA SUBJECT CODE: ECO